Although the reason for the high circulating levels of DKK1 seen in MM patients is not yet fully explained, a monoclonal antibody targeting DKK1, BHQ880, has been developed in view of its key role in the pathology (Iyer et al., 2014). Here, DKK1 is linked to Miyoshi myopathy.